title: The ANBP2 and ALLHAT: conflicting or consistent?
authors.affiliation: National Heart, Lung, and Blood Institute, Bethesda, MD 20892-7936, USA. CutlerJ@nhlbi.nih.gov
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Cutler
mesh_terms: D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001315:Australia; D001581:Benzothiadiazines; D001794:Blood Pressure / Q000187:drug effects; D004232:Diuretics; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014481:United States
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors